Quince Therapeutics, Inc. (QNCX) vs TransCode Therapeutics Inc. (RNAZ)
Quince Therapeutics, Inc. and TransCode Therapeutics Inc. are both Biotechnology companies. Quince Therapeutics, Inc. and TransCode Therapeutics Inc. are of similar size ($30.5M and $27.9M). Across the 7 metrics below, Quince Therapeutics, Inc. leads on 5 and TransCode Therapeutics Inc. on 2.
Valuation
Profitability
| Metric | QNCX | RNAZ | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 784.09% | 429.61% | (57.72%) |
| Return on assets | (76.68%) | (58.12%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack